K13-Propeller Mutations and Malaria Resistance.

  title={K13-Propeller Mutations and Malaria Resistance.},
  author={Johanna Daily},
  journal={The New England journal of medicine},
  volume={374 25},
n engl j med 374;25 nejm.org June 23, 2016 2492 9. Press OW, Li H, Schöder H, et al. US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816. J Clin Oncol 2016 April 11 (Epub ahead of print). 10. Younes A, Connors JM, Park SI, et al. Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin’s lymphoma: a phase 1, open-label, dose… CONTINUE READING


Publications citing this paper.